Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg
$900.00 – $1,800.00
Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg. Pertuzumab biosimilar CHO stable cell line is available for licensing to manufacture the pertuzumab biosimilar protein.The research grade pertuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
- Product Details
- Description
- Additional information
- More Offers
Catalog No. | C006P.05 |
---|---|
Product Name | Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg |
Supplier Name | Syd Labs, Inc. |
Brand Name | Syd Labs |
Synonyms | Anti-ErbB-2 Humanized Monoclonal Antibody, Anti-c-neu Humanized Monoclonal Antibody |
Summary | Recombinant humanized IgG1 Monoclonal Antibody. |
Isotype | Human IgG1 kappa |
Source/Host | The monoclonal antibody pertuzumab biosimilar was produced in the pertuzumab biosimilar CHO stable cell line. |
Specificity/Sensitivity | The monoclonal antibody pertuzumab biosimilar specifically binds to the human HER2/ErbB-2/c-neu. |
Form Of Antibody | 0.2 uM filtered solution, pH 6.0, no stabilizers or preservatives. |
Endotoxin | < 0.05 EU per 1 mg of the protein by the LAL method. |
Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
Shipping | The Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
Note | Pertuzumab biosimilar CHO stable cell line is available for licensing to manufacture the pertuzumab biosimilar protein.The research grade pertuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. |
Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C006P.05: Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg
Recombinant humanized IgG1 Monoclonal Antibody.
Background
Pertuzumab, a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
Syd Labs also provides the following anti-ErbB/HER antibody biosimilar proteins:
Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Panitumumab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Syd Labs also provides the following research grade antibody biosimilar proteins:
Bevacizumab Biosimilar, research grade (VEGF-A)
Ranibizumab Biosimilar, research grade (VEGF-A, Fab produced in E. coli)
Cetuximab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Panitumumab Biosimilar, research grade (HER1, ErbB-1, EGFR)
Trastuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Pertuzumab Biosimilar, research grade (HER2, ErbB-2, c-neu)
Infliximab biosimilar, research grade (TNF alpha)
Adalimumab biosimilar, research grade (TNF alpha)
Rituximab biosimilar, research grade (CD20)
Denosumab biosimilar, research grade (RANKL, RANK ligand, OPGL, TNFSF11, CD254, TRANCE, ODF)
Palivizumab Biosimilar, research grade (RSV)
Omalizumab biosimilar, research grade (IgE)
Eculizumab biosimilar, research grade (C5)
Please remember our product information: Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg: C006P.05 Syd Labs
Additional information
Ship from Country | USA |
---|---|
Size | 20 mg, 5 mg |